Skip to main content
. 2018 Feb 13;8:5. doi: 10.1186/s13601-018-0190-2

Fig. 6.

Fig. 6

Expression of BrdU measured by immunohistochemistry wild type and IL-25 KO mouse models that were sensitized and challenged with OVA or PBS (control) (*p < 0.05, **p < 0.01 and ***p < 0.001, n = 5)